Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1323
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02390414 | The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study | ||
| NCT06422455 | Access to Genetic Testing in Underserved Patients With Cancer | ||
| NCT00766467 | A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas | ||
| NCT03341936 | Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN | ||
| NCT05501704 | ETHAN - ET for Male BC | ||
| NCT05335434 | Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation | ||
| NCT00355407 | Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation | ||
| NCT00004163 | Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | ||
| NCT00953576 | Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer | ||
| NCT03249090 | Electronic Patient Reporting of Symptoms During Cancer Treatment | ||
| NCT03328091 | Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) | ||
| NCT01623349 | Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer | ||
| NCT03219450 | A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. | ||
| NCT00003058 | Troglitazone in Treating Patients With Liposarcoma | ||
| NCT01550458 | Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers | ||
| NCT02207504 | Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer | ||
| NCT01586182 | Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma | ||
| NCT00670982 | Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer | ||
| NCT04943848 | rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG | ||
| NCT02523040 | Lenalidomide for Adult Histiocyte Disorders | ||
| NCT00954720 | Observational Study of Iron Overload in Stem Cell Transplantation | ||
| NCT00398710 | A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia | ||
| NCT03789110 | NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer | ||
| NCT06055296 | Multisite Implementation of COMPRENDO | ||
| NCT03022032 | The HOPE Trial and the SMART Study | ||
| NCT00448721 | A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer | ||
| NCT04421560 | Pembrolizumab, Ibrutinib and Rituximab in PCNSL | ||
| NCT04497142 | Effect of Perampanel on Peritumoral Hyperexcitability in HGG | ||
| NCT02441686 | Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma | ||
| NCT00400946 | 05-001: Treatment of Acute Lymphoblastic Leukemia in Children | ||
| NCT06802146 | Early Intervention in High Risk CCUS | ||
| NCT01659203 | Proton or Photon RT for Retroperitoneal Sarcomas | ||
| NCT03681483 | RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer | ||
| NCT00003966 | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation | ||
| NCT02257541 | BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) | ||
| NCT04758403 | CBCT-Guided Navigational Bronchoscopy For Lung Nodules | ||
| NCT03291951 | FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study | ||
| NCT00142129 | Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia | ||
| NCT05455294 | Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms | ||
| NCT02999477 | A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer | ||
| NCT04066361 | OPTimizing Treatment Focused Genetic Testing IN Cancer | ||
| NCT02282735 | Parental Decision-Making for Children With Relapsed Neuroblastoma | ||
| NCT02390427 | Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer | ||
| NCT03277469 | Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer | ||
| NCT02919969 | Pembrolizumab in Metastatic Anal Cancer | ||
| NCT01596218 | Brentuximab Vedotin for Steroid Refractory GvHD | ||
| NCT01078961 | An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma | ||
| NCT06854003 | BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma | ||
| NCT02135211 | Healthy Directions After Lung Surgery Pilot | ||
| NCT00165464 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer |
